News

Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet.

Wall Street loves a dominant player, and Eli Lilly (NYSE: LLY) looks unstoppable with its obesity blockbusters printing money ...
Al Arabiya English5h

Novo Nordisk’s Wegovy gets accelerated US approval for liver disease MASH

Novo Nordisk said on Friday the US Food and Drug Administration has granted accelerated approval for its weight-loss drug Wegovy to treat a serious liver ...
Indy100 on MSN20h

Is Trump to blame for the UK’s 170% Mounjaro price surge?

The cost of Mounjaro, a popular weight-loss injection, is set to rise sharply in the UK – from £122 to £330 – a 170 per cent ...